BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30144959)

  • 1. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.
    Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A
    Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.
    Chazova IY; Martynyuk TV; Valieva ZS; Gratsianskaya SY; Aleevskaya AM; Zorin AV; Nakonechnikov SN
    Biomed Res Int; 2020; 2020():6836973. PubMed ID: 32626754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension: Real-world data from a Portuguese expert referral centre.
    Gomes A; Cruz C; Rocha J; Ricardo M; Vicente M; Melo A; Santos M; Carvalho L; Gonçalves F; Reis A
    Pulmonology; 2018; 24(4):231-240. PubMed ID: 29674186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.
    Rådegran G; Kjellström B; Ekmehag B; Larsen F; Rundqvist B; Blomquist SB; Gustafsson C; Hesselstrand R; Karlsson M; Kornhall B; Nisell M; Persson L; Ryftenius H; Selin M; Ullman B; Wall K; Wikström G; Willehadson M; Jansson K;
    Scand Cardiovasc J; 2016 Aug; 50(4):243-50. PubMed ID: 27146648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension: A cross-sectional study.
    Nakamura H; Kato M; Nakaya T; Kono M; Tanimura S; Sato T; Fujieda Y; Oku K; Ohira H; Bohgaki T; Yasuda S; Tsujino I; Nishimura M; Atsumi T
    Medicine (Baltimore); 2017 Oct; 96(43):e8349. PubMed ID: 29069014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world, long-term survival of incident patients with pulmonary arterial hypertension.
    Marques-Alves P; Baptista R; Marinho da Silva A; Pêgo M; Castro G
    Rev Port Pneumol (2006); 2017; 23(3):124-131. PubMed ID: 28283462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of long-term prognosis among all subtypes of pulmonary hypertension in Japan.
    Kozu K; Sugimura K; Ito M; Hirata KI; Node K; Miyamoto T; Ueno S; Watanabe H; Shimokawa H;
    Int J Cardiol; 2020 Feb; 300():228-235. PubMed ID: 31813677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension.
    Bartenstein P; Saxer S; Appenzeller P; Lichtblau M; Schwarz EI; Ulrich S
    Respiration; 2018; 96(2):127-137. PubMed ID: 29642071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma markers in pulmonary hypertension subgroups correlate with patient survival.
    Koudstaal T; van Uden D; van Hulst JAC; Heukels P; Bergen IM; Geenen LW; Baggen VJM; van den Bosch AE; van den Toorn LM; Chandoesing PP; Kool M; Boersma E; Hendriks RW; Boomars KA
    Respir Res; 2021 May; 22(1):137. PubMed ID: 33947407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease characteristics and clinical outcome over two decades from the Swiss pulmonary hypertension registry.
    Appenzeller P; Lichtblau M; Berlier C; Aubert JD; Azzola A; Fellrath JM; Geiser T; Lador F; Pohle S; Opitz I; Schwerzmann M; Stricker H; Tamm M; Saxer S; Ulrich S
    Pulm Circ; 2022 Jan; 12(1):e12001. PubMed ID: 35506112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Xu QX; Yang YH; Geng J; Zhai ZG; Gong JN; Li JF; Tang X; Wang C
    Chin Med J (Engl); 2017 Feb; 130(4):382-391. PubMed ID: 28218209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and surgical management for chronic thromboembolic pulmonary hypertension: a single center experience.
    Coronel ML; Chamorro N; Blanco I; Amado V; Del Pozo R; Pomar JL; Badia JR; Rovira I; Matute P; Argemí G; Castellà M; Barberà JA
    Arch Bronconeumol; 2014 Dec; 50(12):521-7. PubMed ID: 24957814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival in pulmonary hypertension in Spain: insights from the Spanish registry.
    Escribano-Subias P; Blanco I; López-Meseguer M; Lopez-Guarch CJ; Roman A; Morales P; Castillo-Palma MJ; Segovia J; Gómez-Sanchez MA; Barberà JA;
    Eur Respir J; 2012 Sep; 40(3):596-603. PubMed ID: 22362843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of chronic thromboembolic pulmonary hypertension following severe forms of acute pulmonary embolism.
    Pargana J; Calé R; Martinho M; Santos J; Lourenço C; Castro Pereira JA; Araújo P; Morgado J; Pereira E; Judas T; Alegria S; Ferreira F; Delerue F; Pereira H
    Rev Port Cardiol; 2023 Dec; 42(12):947-958. PubMed ID: 37652118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in Portugal: first data from a nationwide registry.
    Baptista R; Meireles J; Agapito A; Castro G; da Silva AM; Shiang T; Gonçalves F; Robalo-Martins S; Nunes-Diogo A; Reis A
    Biomed Res Int; 2013; 2013():489574. PubMed ID: 24228252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term data from the Swiss pulmonary hypertension registry.
    Mueller-Mottet S; Stricker H; Domenighetti G; Azzola A; Geiser T; Schwerzmann M; Weilenmann D; Schoch O; Fellrath JM; Rochat T; Lador F; Beghetti M; Nicod L; Aubert JD; Popov V; Speich R; Keusch S; Hasler E; Huber LC; Grendelmeier P; Tamm M; Ulrich S
    Respiration; 2015; 89(2):127-40. PubMed ID: 25661477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
    Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD
    Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic thromboembolic pulmonary hypertension: A 10-year analysis from a Portuguese referral center.
    Samouco G; Fonseca M; Batista Correia J; Santos-Ferreira C; Marques-Alves P; Baptista R; Castro G; Gonçalves L
    Rev Port Cardiol; 2022 Sep; 41(9):741-748. PubMed ID: 36066267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset.
    Channick R; Chin KM; McLaughlin VV; Lammi MR; Zamanian RT; Turricchia S; Ong R; Mitchell L; Kim NH
    Cardiol Ther; 2024 Jun; 13(2):315-339. PubMed ID: 38451426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.